Leptin resistance and excess leptin production result in abnormal appetite, hyperinsulinemia, hypothalamic inflammation, obesity, dyslipidemia, altered blood-brain barrier transport, and the emergence of other metabolic disorders (Gruzdeva et al., 2019). Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.